BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Majchrzak-Celińska A, Warych A, Szoszkiewicz M. Novel Approaches to Epigenetic Therapies: From Drug Combinations to Epigenetic Editing. Genes (Basel) 2021;12:208. [PMID: 33572577 DOI: 10.3390/genes12020208] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 10.0] [Reference Citation Analysis]
Number Citing Articles
1 Mani N, Daiya A, Chowdhury R, Mukherjee S, Chowdhury S. Epigenetic adaptations in drug-tolerant tumor cells. Advances in Cancer Research 2023. [DOI: 10.1016/bs.acr.2022.12.006] [Reference Citation Analysis]
2 Chang T, Lian Z, Ma S, Liang Z, Ma X, Wen X, Wang Y, Liu R. Combination with vorinostat enhances the antitumor activity of cisplatin in castration-resistant prostate cancer by inhibiting DNA damage repair pathway and detoxification of GSH. Prostate 2022. [PMID: 36576015 DOI: 10.1002/pros.24479] [Reference Citation Analysis]
3 Agache I, Zemelka-Wiącek M, Shamji MH, Jutel M. Immunotherapy: State-of-the-art review of therapies and theratypes. J Allergy Clin Immunol 2022;150:1279-88. [PMID: 36328808 DOI: 10.1016/j.jaci.2022.10.007] [Reference Citation Analysis]
4 Elrakaybi A, Ruess DA, Lübbert M, Quante M, Becker H. Epigenetics in Pancreatic Ductal Adenocarcinoma: Impact on Biology and Utilization in Diagnostics and Treatment. Cancers (Basel) 2022;14. [PMID: 36497404 DOI: 10.3390/cancers14235926] [Reference Citation Analysis]
5 Nie Y, Wen L, Song J, Wang N, Huang L, Gao L, Qu M. Emerging trends in epigenetic and childhood trauma: Bibliometrics and visual analysis. Front Psychiatry 2022;13. [DOI: 10.3389/fpsyt.2022.925273] [Reference Citation Analysis]
6 Babar Q, Saeed A, Tabish TA, Pricl S, Townley H, Thorat N. Novel epigenetic therapeutic strategies and targets in cancer. Biochim Biophys Acta Mol Basis Dis 2022;1868:166552. [PMID: 36126898 DOI: 10.1016/j.bbadis.2022.166552] [Reference Citation Analysis]
7 Tulsyan S, Aftab M, Sisodiya S, Khan A, Chikara A, Tanwar P, Hussain S. Molecular basis of epigenetic regulation in cancer diagnosis and treatment. Front Genet 2022;13:885635. [DOI: 10.3389/fgene.2022.885635] [Reference Citation Analysis]
8 Rath S, Chakraborty D, Pradhan J, Imran Khan M, Dandapat J. Epigenomic interplay in tumor heterogeneity: Potential of epidrugs as adjunct therapy. Cytokine 2022;157:155967. [PMID: 35905624 DOI: 10.1016/j.cyto.2022.155967] [Reference Citation Analysis]
9 Karami Fath M, Azargoonjahromi A, Kiani A, Jalalifar F, Osati P, Akbari Oryani M, Shakeri F, Nasirzadeh F, Khalesi B, Nabi-Afjadi M, Zalpoor H, Mard-Soltani M, Payandeh Z. The role of epigenetic modifications in drug resistance and treatment of breast cancer. Cell Mol Biol Lett 2022;27:52. [PMID: 35764927 DOI: 10.1186/s11658-022-00344-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
10 Hussain A, Tebyaniyan H, Khayatan D. The Role of Epigenetic in Dental and Oral Regenerative Medicine by Different Types of Dental Stem Cells: A Comprehensive Overview. Stem Cells Int 2022;2022:5304860. [PMID: 35721599 DOI: 10.1155/2022/5304860] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Zhao L, Guo H, Chen X, Zhang W, He Q, Ding L, Yang B. Tackling drug resistance in ovarian cancer with epigenetic targeted drugs. Eur J Pharmacol 2022;927:175071. [PMID: 35636522 DOI: 10.1016/j.ejphar.2022.175071] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Dorna D, Paluszczak J. The Emerging Significance of Histone Lysine Demethylases as Prognostic Markers and Therapeutic Targets in Head and Neck Cancers. Cells 2022;11:1023. [DOI: 10.3390/cells11061023] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
13 Poggi A, Zocchi MR. Natural killer cells and immune-checkpoint inhibitor therapy: Current knowledge and new challenges. Mol Ther Oncolytics 2022;24:26-42. [PMID: 34977340 DOI: 10.1016/j.omto.2021.11.016] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 10.0] [Reference Citation Analysis]
14 Dhawan P, Vasishta S, Balakrishnan A, Joshi MB. Mechanistic insights into glucose induced vascular epigenetic reprogramming in type 2 diabetes. Life Sciences 2022. [DOI: 10.1016/j.lfs.2022.120490] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
15 Zhang H, Zhao H, Wang H, Yin Z, Huang K, Yu M. High PLA2 level is correlated with glioblastoma progression via regulating DNA replication. J Cell Mol Med 2022. [PMID: 35166019 DOI: 10.1111/jcmm.17140] [Reference Citation Analysis]
16 Kuo FC, Chao CT, Lin SH. The Dynamics and Plasticity of Epigenetics in Diabetic Kidney Disease: Therapeutic Applications Vis-à-Vis. Int J Mol Sci 2022;23:843. [PMID: 35055027 DOI: 10.3390/ijms23020843] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
17 Paweł K, Maria Małgorzata S. CpG Island Methylator Phenotype-A Hope for the Future or a Road to Nowhere? Int J Mol Sci 2022;23:830. [PMID: 35055016 DOI: 10.3390/ijms23020830] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
18 Cecil CAM, Nigg JT. Epigenetics and ADHD: Reflections on Current Knowledge, Research Priorities and Translational Potential. Mol Diagn Ther 2022;26:581-606. [PMID: 35933504 DOI: 10.1007/s40291-022-00609-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Stein RA, Deverakonda AN. Epigenetics in Cancer Biology. Interdisciplinary Cancer Research 2022. [DOI: 10.1007/16833_2022_86] [Reference Citation Analysis]
20 Varghese B, Del Gaudio N, Cobellis G, Altucci L, Nebbioso A. KDM4 Involvement in Breast Cancer and Possible Therapeutic Approaches. Front Oncol 2021;11:750315. [PMID: 34778065 DOI: 10.3389/fonc.2021.750315] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
21 Burkitt K, Saloura V. Epigenetic Modifiers as Novel Therapeutic Targets and a Systematic Review of Clinical Studies Investigating Epigenetic Inhibitors in Head and Neck Cancer. Cancers (Basel) 2021;13:5241. [PMID: 34680389 DOI: 10.3390/cancers13205241] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
22 Dobre EG, Constantin C, Costache M, Neagu M. Interrogating Epigenome toward Personalized Approach in Cutaneous Melanoma. J Pers Med 2021;11:901. [PMID: 34575678 DOI: 10.3390/jpm11090901] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
23 Mora Y, Reyes ME, Zanella L, Mora B, Buchegger K, Ili C, Brebi P. Resistance to platinum-based cancer drugs: a special focus on epigenetic mechanisms. Pharmacogenomics 2021. [PMID: 34281355 DOI: 10.2217/pgs-2021-0020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
24 Park HS, Kim J, Ahn SH, Ryu HY. Epigenetic Targeting of Histone Deacetylases in Diagnostics and Treatment of Depression. Int J Mol Sci 2021;22:5398. [PMID: 34065586 DOI: 10.3390/ijms22105398] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
25 Majchrzak-Celińska A, Misiorek JO, Kruhlenia N, Przybyl L, Kleszcz R, Rolle K, Krajka-Kuźniak V. COXIBs and 2,5-dimethylcelecoxib counteract the hyperactivated Wnt/β-catenin pathway and COX-2/PGE2/EP4 signaling in glioblastoma cells. BMC Cancer 2021;21:493. [PMID: 33941107 DOI: 10.1186/s12885-021-08164-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 4.5] [Reference Citation Analysis]